Cardiovascular and renal protection of SGLT2i in early-stage type 2 diabetes: the DIAB-CV-AP study.Jorge Pablo-Ortega, Sergio Cinza‐Sanjurjo, Pilar Mazón‐Ramos et al.|Nutrition Metabolism and Cardiovascular Diseases|2026Cited by 0